Trivascular Technologies Inc (TRIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,995 | -14,423 | -50,308 | -36,819 | -24,116 |
| Depreciation Amortization | 609 | 295 | 1,479 | 1,209 | 894 |
| Accounts receivable | -917 | -807 | -3,033 | -2,432 | -2,280 |
| Accounts payable and accrued liabilities | 199 | 417 | 462 | 705 | 529 |
| Other Working Capital | -528 | -346 | -573 | -1,026 | -693 |
| Other Operating Activity | 2,986 | 1,523 | 5,057 | 4,033 | 2,964 |
| Operating Cash Flow | $-26,646 | $-13,341 | $-46,916 | $-34,330 | $-22,702 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -67 | -10 | -221 | -202 | -191 |
| Other Investing Activity | 0 | 0 | 13 | 0 | 0 |
| Investing Cash Flow | $-67 | $-10 | $-208 | $-202 | $-191 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,000 | 6,000 | N/A | 0 | 0 |
| Debt Repayment | -4,599 | N/A | N/A | 0 | N/A |
| Common Stock Issued | 82,869 | 1,456 | 59 | 31 | 23 |
| Other Financing Activity | 0 | -814 | 39,772 | 0 | 0 |
| Financing Cash Flow | $84,270 | $6,642 | $39,831 | $31 | $23 |
| Exchange Rate Effect | -8 | 10 | 8 | -33 | 4 |
| Beginning Cash Position | 38,108 | 38,108 | 45,393 | 45,393 | 45,393 |
| End Cash Position | 95,657 | 31,409 | 38,108 | 10,859 | 22,527 |
| Net Cash Flow | $57,549 | $-6,699 | $-7,285 | $-34,534 | $-22,866 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,646 | -13,341 | -46,916 | -34,330 | -22,702 |
| Capital Expenditure | -67 | -10 | -221 | -202 | -191 |
| Free Cash Flow | -26,713 | -13,351 | -47,137 | -34,532 | -22,893 |